Activators of THAP10 represent a class of compounds that indirectly engage with the transcriptional and epigenetic mechanisms within the cell. These compounds may alter the chromatin state, modify DNA methylation, or affect histone modifications, which can influence the accessibility of transcription factors like THAP10 to their DNA binding sites, thereby modulating gene expression patterns. The primary mode of action for these chemicals involves the inhibition of enzymes that modulate the structure and function of chromatin, such as histone deacetylases and DNA methyltransferases. By inhibiting these enzymes, compounds like Sodium Butyrate, Trichostatin A, Suberoylanilide Hydroxamic Acid, and VPA can increase the acetylation of histones, which is generally associated with an open chromatin configuration and active transcription. This change in the chromatin landscape can facilitate transcription factors like THAP10 to engage more effectively with their target DNA sequences, enhancing their transcriptional output.
Additionally, the inhibition of DNA methyltransferases by chemicals such as 5-Azacytidine, Zebularine, and RG108 can lead to DNA demethylation. This reduction in DNA methylation can reactivate genes that have been silenced by methylation and possibly those under the regulatory scope of THAP10, altering its activity indirectly. In contrast, of histone methyltransferases, like BIX-01294 and EPZ004777, can change the histone methylation marks that are critical for the recruitment of transcription factors and the initiation of gene transcription. The chemical class of THAP10 activators is not limited to those altering the histone code or DNA methylation patterns. Compounds such as Parthenolide and Disulfiram can modify transcription factor activity and gene expression through the alteration of cellular signaling pathways like NF-κB, which has widespread effects on cell survival, proliferation, and differentiation. Through these multifaceted mechanisms, the above-mentioned compounds can indirectly modulate the activity of THAP10 within the cellular milieu.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $31.00 $47.00 $84.00 $222.00 | 19 | |
Histone deacetylase inhibitor that promotes acetylation of histones, leading to a more relaxed chromatin structure and potentially enhancing the transcriptional activity of THAP10 by improving access to DNA. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Another histone deacetylase inhibitor, Trichostatin A, can lead to changes in gene expression patterns that may upregulate factors interacting with or regulating THAP10. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
A DNA methyltransferase inhibitor that can cause DNA demethylation, potentially affecting the expression of genes regulated by THAP10 or influencing its binding to DNA. | ||||||
Zebularine | 3690-10-6 | sc-203315 sc-203315A sc-203315B | 10 mg 25 mg 100 mg | $129.00 $284.00 $1004.00 | 3 | |
DNA methyltransferase inhibitor, similar in function to 5-Azacytidine, potentially resulting in changes in the chromatin that could enhance THAP10's access to its target genes. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $133.00 $275.00 | 37 | |
Histone deacetylase inhibitor that could potentially result in an increase in THAP10 target gene expression by changing the chromatin state around those genes. | ||||||
RG 108 | 48208-26-0 | sc-204235 sc-204235A | 10 mg 50 mg | $131.00 $515.00 | 2 | |
A non-nucleoside DNA methyltransferase inhibitor that can alter gene expression, potentially modifying the repertoire of genes THAP10 regulates. | ||||||
Valproic Acid | 99-66-1 | sc-213144 | 10 g | $87.00 | 9 | |
Histone deacetylase inhibitor which may augment the transcriptional activity of THAP10 by allowing more accessible chromatin configuration. | ||||||
Histone Lysine Methyltransferase Inhibitor Inhibitor | 935693-62-2 (free base) | sc-202651 | 5 mg | $151.00 | 4 | |
A histone methyltransferase inhibitor that could modify the methylation landscape, possibly impacting gene sets regulated by THAP10. | ||||||
Epz004777 | 1338466-77-5 | sc-507560 | 100 mg | $575.00 | ||
A DOT1L inhibitor that affects histone H3K79 methylation, potentially influencing chromatin dynamics and the expression of THAP10 target genes. | ||||||
Parthenolide | 20554-84-1 | sc-3523 sc-3523A | 50 mg 250 mg | $81.00 $306.00 | 32 | |
NF-κB pathway inhibitor that can affect a range of cellular processes, possibly modulating the activity of THAP10 by altering the transcription of genes within this pathway. | ||||||